大摩发布研报称，予平安好医生(01833)"与大市同步"评级。平安好医生公布，李斗辞任董事会主席、 执行董事、首席执行官，非执行董事郭晓涛获委任为董事会主席，而何明科获委任为首席执行官、执行 董事、董事会可持续发展委员会成员及授权代表。该行提到，郭晓涛先生曾负责平安集团在医疗健康、 科技和养老领域的整体业务战略，并担任北大医疗管理、平安银行、平安产险、平安寿险的董事，以及 金融壹账通的非执行董事。何明科先生在数字健康和平台管理方面拥有卓越的往绩。在加入平安好医生 之前，他曾领导百度医疗健康业务。 10月7日，平安好医生(01833)发布公告称，李斗因个人工作安排原因辞任公司董事会主席、执行董事、 首席执行官一职。公司董事会委任郭晓涛先生为董事会主席，委任何明科先生为首席执行官、执行董 事，自公告之日起生效。 平安好医生表示，上述人事调整不影响公司正常运营，公司治理结构将继续保持规范高效。作为平安集 团医疗养老生态圈的旗舰，将深入贯彻平安集团"综合金融+医疗养老"双轮驱动战略，深化发展"医险协 同"模式，持续加强家庭医生和养老管家核心枢纽建设，通过医疗AI闭环服务能力及应用落地，为用户 提供"省心、省时、又省钱 ...

董事会亦留意到，公司就其于2025年9月10日举行的第十届H2H医疗服务生态大会而刊发的新闻稿，其 中包括若干公司最新消息，包括(i)公司发布专有「杏石」大模型("杏石大模型")作为其五项旗舰应用(AI 用药助手、AI健康管家、AI医生助手、AI学术助手及AI搜索)的基石，赋能先进临床诊断支援及个性化 慢病管理；(ii)与信达生物制药("信达")达成战略合作伙伴关系，整合方舟H2H数字健康生态系统与信达 体重管理疗法管线，初步利用公司之杏石大模型，为信达的玛仕度肽提供个性化数字维护及依从性支 持，在中国快速增长的体重管理市场提高患者的疗效；及(iii)与浙江大塚制药有限公司("大塚")展开战略 合作，结合公司的AI技术优势及大塚的创新药组合，共同开发覆盖药物支援服务、针对性病患外展项 目及健康教育计划的全方位数字解决方案。 经作出在相关情况下有关公司的该等合理查询后，董事会确认(i)新闻稿所含资料并不构成根据上市规则 第13.09(2)条或香港法例第571章证券及期货条例第XIVA部项下之内幕消息条文所规定之内幕消息；及 (ii)其亦并不知悉股份交易价格上升之任何理由，或为避免股份出现虚假市场而须作出公告之任 ...

Financial Data and Key Metrics Changes - The company has adjusted its net dollar retention expectations from 103% to 93% due to pricing pressure and client behavior changes during the Egnyte migration [15][19][22] - The average sales benchmark (ASB) has shifted to the lower end of the range, now between $300,000 and $700,000, primarily due to tighter scoping rather than lower gross margins, which remain strong at over 80% [27][29] Business Line Data and Key Metrics Changes - The company has added 22 new platform clients since the beginning of the year, bringing the total to 152 platform clients [23] - The focus for cross-selling is on adjacent applications, particularly in the finance category, which offers clear near-term ROI for clients [31][32] Market Data and Key Metrics Changes - Many clients are currently using the 2026 budgeting cycle to reassess their needs and strategies in light of recent Medicaid cuts and funding changes [20] - The company is experiencing a stronger start to Q3 compared to typical quiet quarters, indicating potential recovery in client engagement [18] Company Strategy and Development Direction - The company is focusing on leveraging its existing client relationships to roll out AI capabilities without requiring new contracts, capitalizing on its incumbency advantage [52] - There is a strategic shift towards tech-led solutions, with a goal to increase the proportion of revenue from technology services compared to professional services [42] Management's Comments on Operating Environment and Future Outlook - Management acknowledges that the current macro environment is challenging, particularly for not-for-profit health systems, which are slower to adapt to significant funding cuts [16] - The company expects the headwind to dollar-based retention to be a near-term issue, with a return to over 100% retention anticipated by 2027 [26][22] Other Important Information - The company has identified over $40 million in savings from a recent restructuring, which will positively impact EBITDA in the upcoming quarters [49][54] - There is no anticipated further M&A activity in the near to mid-term, as the company focuses on digesting recent acquisitions and maximizing cross-sell opportunities [58] Q&A Session Summary Question: What is the impact of the Egnyte migration on dollar-based retention? - Management explained that the migration has led to a reduction in dollar-based retention due to clients opting for immediate savings rather than cross-selling opportunities [15][19] Question: How is the company addressing the tighter scoping in sales? - The company noted that while scoping is tighter, it has maintained good gross margins and is still signing meaningful business [29][30] Question: What is the company's strategy regarding professional services? - Management clarified that while they are reducing reliance on professional services, they still see value in providing deep domain expertise where necessary [39][42] Question: How is AI influencing the company's operations? - The company is increasingly using AI in R&D, which is expected to provide significant operating leverage and improve efficiency [48][49] Question: What are the capital strategy priorities moving forward? - The focus is on achieving meaningful free cash flow in 2026, with plans for share repurchase and debt repayment as primary uses of capital [57][58]

Group 1 - The core viewpoint of the article emphasizes the establishment of a modern industrial system in Hainan, focusing on the digital economy as a key area for innovation and growth [1] - The action plan aims to transform the Haikou Revival City and Hainan Ecological Software Park into innovation-driven and application-driven digital economy industry clusters [1] - By 2027, the core revenue of the digital economy in Hainan is projected to reach 220 billion yuan [1] Group 2 - The plan includes accelerating the layout of computing power industries and fostering a data element market to promote secure and orderly data flow [1] - The strategy involves leveraging technologies such as blockchain, AI, and big data to enhance sectors like digital health, digital entertainment, and shared platforms [1] - There is a focus on industries such as gaming export, data processing, semiconductor chips, and integrated circuits [1] Group 3 - The initiative also aims to promote the digital transformation of enterprises in sectors like petrochemical new materials, modern biomedicine, high-end food processing, and equipment manufacturing [1] - The goal is to advance the integration of digital and physical industries through these transformations [1]

Group 1 - The Hangzhou Municipal Financial Supervision Administration has released the latest list of 315 key enterprises planned for listing, covering sectors such as biomedicine, digital economy, high-end manufacturing, and modern services [1][2] - Notable companies on the list include Zhejiang Salt Co., Zhejiang Shipping, Hu Qing Yu Tang, Hangzhou Rural Commercial Bank, Hikrobot, and others, indicating an expansion of the capital market's reserve strength in Hangzhou [1] - The list is updated regularly, removing companies that have gone public or committed major violations, while including those in the IPO process or receiving significant investment from well-known institutions [1] Group 2 - The new listing "reserve army" includes high-tech companies in artificial intelligence and biotechnology, such as Ruier IoT Technology, Norkang Neuroelectronics, and Lianchuan Biotechnology [2] - Several digital health companies, including San Tan Medical and Ding Xiang Yuan, are also featured on the list, reflecting a strong presence in the digital health sector [2] - In addition, companies in the new energy and environmental sectors, such as Longyan Energy Technology and Zhaosheng Technology, have been included, showcasing a diverse range of industries represented [2]

Group 1 - The latest list of key companies planned for listing in Hangzhou includes 315 firms across various sectors such as biomedicine, digital economy, high-end manufacturing, and modern services [1][2] - Notable companies on the list include traditional brands like Hu Qing Yu Tang and Zhejiang Salt Industry Co., as well as industry leaders like Zhejiang Long Aviation and Hikvision Robotics [1][2] - Emerging tech companies from the "Hangzhou Six Little Dragons," such as Qunhe Information and Yunsenshu Technology, are also included in the updated list [1][2] Group 2 - The technology and medical sectors are highlighted as two major areas with a significant number of promising companies, including Qunhe Information Technology and WeDoctor, a digital health unicorn [2] - Hu Qing Yu Tang, a century-old brand, and several other medical firms like Nucleon Health and Sugarji Medical are also part of the growing biomedical landscape in Hangzhou [2] Group 3 - The Hangzhou government has been actively promoting the capital market, launching initiatives like the "Phoenix Action Plan" to support strategic emerging industries [3] - By mid-2024, the Hangzhou Innovation Fund and other related funds had approved a total fund size of 170.6 billion yuan, investing in 1,580 projects and 2,600 companies, with over 90% of the funding directed towards private enterprises [3] Group 4 - As of July 15, there are 234 listed companies in Hangzhou, with 20 companies having a market capitalization exceeding 30 billion yuan [4] - The Binjiang District is home to the highest number of listed companies, accounting for 19.7% of the total, while other districts like Xihu and Yuhang also contribute significantly [4] - Four Hangzhou companies, including Zhongce Rubber and Xinkai Technology, successfully went public on the A-share market this year, with Zhongce Rubber achieving a market value close to 50 billion yuan shortly after its IPO [4] Group 5 - The Hong Kong capital market is increasingly attracting Hangzhou companies, with 63 firms listed as of July 15 [6] - Recent listings include Saint Bella, which became the first global family quality care stock, and TIDE Pharmaceutical, which debuted on the Hong Kong Stock Exchange [6] - Several other Hangzhou companies are in the process of applying for listings on the Hong Kong Stock Exchange, indicating a growing trend of companies seeking opportunities in this market [6]

Group 1 - The US IPO market has shown a significant recovery in 2023, with over 170 companies completing listings and raising more than $11 billion, a 77% increase compared to the same period last year [1] - A record number of companies saw their stock prices double on the first day of trading, with notable examples including Newsmax, Circle Internet Group, and Airo Group Holdings [3][4] - Historical data indicates that extreme first-day price increases often do not lead to sustained long-term returns, with nearly 90% of companies that doubled on their first day experiencing negative three-year returns [3][4] Group 2 - The current IPO market recovery is driven by both professional traders and retail investors, but companies are increasingly allocating shares to mutual funds that promise long-term holding [4] - The IPO market's recovery is facing challenges, including geopolitical tensions and trade issues, which may affect the sustainability of this trend [5] - There is a shift in global capital markets, with Hong Kong's IPO market significantly increasing, potentially making it the largest listing destination this year, reflecting a change in companies' preferences for listing locations [6]

Core Viewpoint - MicroPulse has submitted its IPO application to the Hong Kong Stock Exchange, aiming to enhance its AI medical capabilities and expand its healthcare management ecosystem, while attracting more investors for long-term development [1] Financial Performance - MicroPulse has reported continuous losses over the past three years, with revenues of 5.12 billion, 6.28 billion, and 6.53 billion yuan for 2022, 2023, and 2024 respectively, and net losses of 4.14 billion, 1.50 billion, and 1.93 billion yuan for the same years [2] - The company's revenue is primarily derived from three segments: full-course management services (72% of revenue), medical health product sales (19.4%), and insurance brokerage services (8.6%) for 2024 [2] Business Strategy - MicroPulse has developed a clear strategy to achieve profitability, focusing on controlling operational costs, particularly in sales and distribution, and leveraging government policies and AI technology to streamline processes [3] - The company aims to create a sustainable and diversified revenue model by expanding into adjacent fields such as insurance brokerage and medical health product sales, enhancing patient engagement and lifetime value [3] Gross Margin Analysis - MicroPulse's gross margin has been below 20% for three consecutive years (17.2%, 18.9%, and 19.9% from 2022 to 2024), attributed to strategic pricing and the initial phase of its business layout [4] - The company believes that while low gross margins may impact short-term performance, they will lead to a more stable customer base and sustained revenue in the long run [4] Competitive Landscape - The digital health sector is competitive, with listed companies such as Beijing New Oxygen Technology, Alibaba Health, JD Health, and Dingdang Health, alongside numerous unlisted firms also entering the market [5] Market Potential - MicroPulse is seen to possess unique advantages and growth potential, with the IPO expected to provide additional funding to solidify its business layout and scale operations towards profitability [6]

Group 1 - The fourth China-Central and Eastern European Countries Expo and International Consumer Goods Expo opened in Ningbo, Zhejiang, focusing on economic cooperation, technological innovation, and cultural exchange [1] - The exhibition area for Central and Eastern European countries covers 20,000 square meters with over 400 exhibitors showcasing more than 8,000 unique products [1] - The expo features participation from 14 Central and Eastern European countries and 9 other countries, expanding from "Central and Eastern Europe" to "Central and Eastern Europe+" [1] Group 2 - Livestocker, a Hungarian digital animal farm software provider, showcased a solution that enhances farm productivity through integrated management across mobile, computer, IoT, and cloud data [2] - 24alife from Slovenia focuses on digital health and remote patient monitoring, aiming to connect with large Chinese enterprises to promote health awareness [2] - The expo highlights the transition from "Made in China" to "Intelligent Manufacturing in China," with products demonstrating high cost-effectiveness, quality, and technological content [2] Group 3 - The Consumer Direct Procurement Conference held during the expo emphasized "precise matching," facilitating connections between over 40 procurement representatives from 25 countries and more than 50 suppliers from various Chinese provinces [2] - Nigerian buyer Francis attended the direct procurement conference with a detailed purchasing list, having previously established long-term partnerships with Chinese suppliers [3] - The export consumer goods exhibition area spans 60,000 square meters with 1,028 participating companies, including local Ningbo enterprises aiming to expand their customer base in Central and Eastern Europe [3] Group 4 - Chinese State Councilor Chen Yiqin emphasized China's commitment to multilateralism and the expansion of imports from Central and Eastern European countries, aiming to enhance bilateral trade and cooperation in high-quality initiatives [4] - The expo is expected to attract over 15,000 professional visitors, including more than 3,000 foreign buyers from 72 countries, with anticipated procurement intentions exceeding 10 billion yuan from Central and Eastern Europe [4]

Group 1: Event Overview - The Fourth China-Central and Eastern European Countries Expo and International Consumer Goods Expo opened in Ningbo, Zhejiang on May 22, focusing on economic cooperation, technological innovation, and cultural exchange [1][9] - The expo featured over 400 exhibitors and more than 8,000 types of Central and Eastern European specialty products, expanding participation from 14 Central and Eastern European countries to include 9 additional countries [3] Group 2: Business Opportunities - A procurement signing event resulted in 24 projects with a total value of 2.49 billion yuan, covering various categories such as mineral procurement, pet health products, skiing equipment, juice, and alcoholic beverages [1] - Companies like Livestocker from Hungary and 24alife from Slovenia showcased digital solutions for agriculture and health monitoring, respectively, indicating a strong interest in the Chinese market's potential for digitalization and health services [5][6] Group 3: Market Potential - The expo is expected to attract over 15,000 professional visitors, with more than 3,000 foreign buyers from 72 countries and regions, aiming to achieve import procurement intentions exceeding 10 billion yuan from Central and Eastern Europe [9] - Ningbo's local enterprises, such as Ningbo Ruyi Co., are leveraging the expo to expand their customer base, as exports to Central and Eastern European countries account for approximately 20% to 30% of their business [8] Group 4: Government Support - Chinese officials emphasized the commitment to multilateralism and the expansion of imports from Central and Eastern European countries, aiming to enhance bilateral trade and cooperation in high-quality initiatives like the Belt and Road [9] - Ningbo aims to create a favorable business environment to facilitate trade and investment, focusing on emerging sectors such as artificial intelligence and renewable energy [8]